Under the patronage of
H.E. Sheikh Nahayan Mabarak Al Nahayan
Cabinet Member, Minister of Tolerance and Coexistence & President of UAE Genetic Diseases Association.
HIGHLIGHTS FROM 2022 EDITION

2
Co-located Events
2
World-Class Conferences
1
Dedicated Exhibition
5,500+
Targeted Visitors
150+
International Speakers
PrecisionMed Exhibition & Summit, in Dubai on 23-24 May 2023 will provide a unique opportunity for healthcare providers, academic scientists and industry experts in this eco system to share knowledge and make connections.
Precision medicine describes the evolving world of personalised medicine and including the use of biomarkers, targeted therapies and the integration of patient health data to translate scientific advances into human health.
Personalised solutions have gained wide traction in genomics & targeted cancer therapies; regenerative medicine, and now include a wide range of diagnostics and treatments for both rare and common diseases.

Discover how precision medicine is taking healthcare from “one size fits all” to a targeted approach.

Exhibition
Discover latest solutions across all areas of precision medicine from 40+ participating countries, including the UK, USA, Germany, and more!

Summit
Learn from 150+ thought leaders and industry experts who will dive deep into the new frontiers of precision medicine technologies, trends, digitisation and more.

Networking & Side Events
Make connections with influential professionals and practitioners in precision medicine to enhance your career, skills, and genome knowledge.

EMERGE GHI
At our co-located event, witness history in the making as aspiring health-tech startups deliver their pitches to source funding from ready investors.
HEALTHCARE REVOLUTIONARIES TAKING THE STAGE (2022 speakers)

Professor Dame Sue Hill
Chief Scientific Officer, England
Exclusive Pre-recorded Session


Min S. Park, PhD
CSO, Sanimed International, Abu Dhabi


H.E Dr. Maryam Matar
Founder and Chairperson, UAE Genetic Diseases Association (UAEGDA)


Robert C. Green, MD, MPH
Professor of Medicine, Harvard Medical School, Geneticist, Mass General Brigham, Broad Institute; Director, Genomes2People Research Program


Ahmad Abou Tayoun, PhD, FACMG
Director, Genomics Center at Al Jalila Children’s; Associate
Professor of Genetics, Mohammed Bin Rashid University of Medicine and Health Sciences


Heidi Rehm, PhD
Chief Genomics Officer, Department of Medicine, MGH; Co-Director, Medical and Population Genetics, Broad Institute
Exclusive Pre-recorded Session


Hinda Daggag, PhD
Corporate Head of Genetic Projects, SEHA


Khalid Fakhro, PhD
Chief Research Officer,
Sidra Medicine


Fatma Al Jasmi, MBBS, FRCPC, FCCMG
Chair of Genetic & Genomic Department, College of Medicine & Health Science, UAE University


Richard O Kennedy,
B.Sc., Ph.D., C. Biol., FRSB., F.I.Biol.I., Dip. F.S., Dip. C.S., Dip. Computing, MRIA
Vice-President for Research, Hamad Bin Khalifa University; and Vice-President for Research, Development and Innovation (RDI), Qatar Foundation


Dr Younes Mokrab
Principal investigator, Head of Medical and Population Genomics Lab, Sidra Medicine


Marjane Le Bagousse, MD, MSc, EM
Medical Director,
Veracyte Immuno-Oncology


Aaron Han, MD, PhD
Consultant, Pathology, COVID Lab, Infection Control, King’s College Hospital London – UAE


Sarah Chahine
Emerging Markets Leader for Clinical Sequencing Division, Thermo Fisher Scientific


Dr. Ihsan Almarzooqi
Co-Founder & Managing Director, Glucare

The estimated precision medicine market valuation by the year 2025 is about USD 126 billion. The compound annual growth rate of the market is predicted to be 12.48% during the forecast period (2017-2025).
*Source: Market Research Future
Why attend PrecisionMed Summit
- Increase your understanding of the basis for current effective targeted therapies in disease based on molecular, environmental, and patient lifestyle factors.
- Learn more about the methods used to analyse patient diagnostic and molecular data, including the concepts of deep dive data extraction and management, molecular profiling of individual diseases, and digitisation of healthcare delivery.
- Identify global and regional unmet needs in healthcare with the capacity to reduce the burden of malignancy and chronic diseases.
- Update your understanding of current diagnostic and therapeutic clinical guidelines and best practices in precision medicine in all areas.
- Network with global key opinion leaders, scientists, healthcare professionals, policymakers, and managers.
- Explore new products, technologies & services will be exhibited by global experts and suppliers with expertise in the development and application of molecular diagnostics, tele-health, and eHealth tools that guide individualised or personalised patient diagnosis and treatment.
- Earn CME/CPD accreditation points.
